IP Library Patent Application 13964703
Patent Application
App. No. 13/964,703

ILCS BASED PATTERN RECOGNITION OF SEPSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/964,703
Abstract

The present invention refers to a method for recognizing and/or characterizing cellular activity patterns, in particular for diagnostic purposes and/or for tracking the therapy of diseases. Blood cells are stimulated in a culture medium at least with toll-like receptor ligands (TLR ligands) and the stimulated blood cells and/or the culture medium are examined.

Claims (22)

1 - 55 . (canceled)

56 . A method for the pre-clinical testing of an agent for a desired activity or lack of activity, comprising:

a) providing a cell culture system comprising mutually communicating first and second compartments, and further comprising a separation layer that is permeable to at least one substance secreted from a cell, wherein the first compartment comprises a syntopic culture of tissue cells and immune cells, and wherein the second compartment comprises a blood cell culture;

b) contacting the cell culture system with a candidate agent;

c) incubating the cell culture system in the presence of the candidate agent; and

d) analyzing cellular activity indicators.

wherein the cellular activity indicators are indicative of the presence or absence of a desired activity of the agent.

57 . The method of claim 56 , wherein the cell culture system is primed with a mediator or activator prior to contact with the candidate agent.

58 . The method of claim 56 , wherein the cells of the cell culture system are separated from the cell culture system prior to screening for cellular activity indicators.

59 . The method of claim 56 , wherein the immune cells comprise phagocytosing immune cells.

60 . The method of claim 59 , wherein the phagocytosing immune cells are monocytes or macrophages or both.

61 . The method of claim 56 , wherein the tissue cells comprise epithelial cells or epitheliod cells.

62 . The method of claim 61 , wherein the epithelial cells are lined around blood vessels.

63 . The method of claim 61 , wherein the epithelial cells are intestinal epithelial cells.

64 . The method of claim 56 , wherein the tissue cells comprise bronchial cells.

65 . The method of claim 56 , wherein the tissue cells comprise skin cells cells.

66 . The method of claim 56 , wherein the tissue cells comprise synovial cells.

67 . The method of claim 56 , wherein the tissue cells comprise chondrocytes.

68 . The method of claim 56 , wherein the tissue cells comprise human cells.

69 . The method of claim 56 , wherein the separation layer is permeable to a substance secreted from one or more cells in the culture.

70 . The method of claim 56 , wherein the separation layer comprises pores having a diameter of between about 0.1 to about 5 μm.

71 . The method of claim 70 , wherein the separation layer comprises pores having a diameter of between about 0.2 to about 0.45 μm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2014
From: SCHMOLZ, MANFRED; SCHNEIDER, MARION
To: MYRIAD GENETICS, INC.
Reel/Frame 032032/0245 →